Sigma Metric Analysis
With all the controversy raging over the FDA Draft Guidelines for new glucose meters, let's remind ourselves of the performance that we see currently on the market. In this example, we'll evaluate three different glucose monitoring systems and see if they meet today's goals and possibly tomorrow's tighter goals...
An analysis of 4 different point-of-care (POC) analyzers and one POC device for HbA1c, based on a study published in 2012. The focus of the study was to find practical POC devices that could support faster decision making for the country's large HIV population. The question is, do any POC devices provide adequate quality for that type of clinical care?
Glucose meters are coming under renewed scrutiny - off-label use with critcally ill patients, infection issues, and new draft guidelines for tighter requirements for FDA clearance. We take a look at a current glucose meter to see if current performance is meeting today's goals - and possibly tomorrow's...
An analysis of 5 different point-of-care (POC) analyzers for C-Reactive Protein (CRP). Many years ago, assays were considered to be too imprecise to support their clinical use. Are the latest instruments any better?
A recent online publication combined a laboratory and field evaluation of two POC testing devices for lipids and glucose. Are we seeing good POC performance in real-world settings?